सिंगापुर -
अंग्रेज़ी -
HSA (Health Sciences Authority)
soliqua solution for injection in a pre-filled pen 100unitsml + 33mcgml
sanofi-aventis singapore pte. ltd. - insulin glargine; lixisenatide - injection, solution - insulin glargine 100 units/ml; lixisenatide 33μg/ml
सिंगापुर -
अंग्रेज़ी -
HSA (Health Sciences Authority)
soliqua solution for injection in a pre-filled pen 100unitsml + 50mcgml
sanofi-aventis singapore pte. ltd. - insulin glargine; lixisenatide - injection, solution - insulin glargine 100 units/ml; lixisenatide 50 μg/ml
दक्षिण अफ़्रीका -
अंग्रेज़ी -
South African Health Products Regulatory Authority (SAHPRA)
saxenda injection
novo nordisk (pty) ltd û (rivonia) - injection - see ingredients - each 1,0 ml solution contains liraglutide 6,0 mg
सिंगापुर -
अंग्रेज़ी -
HSA (Health Sciences Authority)
ozempic 0.25mg 0.5mgdose solution for injection in pre-filled pen 1.34mgml
novo nordisk pharma (singapore) pte ltd - semaglutide - injection, solution - semaglutide 1.34mg/ml
सिंगापुर -
अंग्रेज़ी -
HSA (Health Sciences Authority)
ozempic 1mgdose solution for injection in pre-filled pen 1.34mgml
novo nordisk pharma (singapore) pte ltd - semaglutide - injection, solution - semaglutide 1.34mg/ml
इसराइल -
अंग्रेज़ी -
Ministry of Health
byetta 5 mcg
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
इसराइल -
अंग्रेज़ी -
Ministry of Health
byetta 5 mcg
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
इसराइल -
अंग्रेज़ी -
Ministry of Health
byetta 10 mcg
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
इसराइल -
अंग्रेज़ी -
Ministry of Health
byetta 10 mcg
astra zeneca israel ltd - exenatide 250 mcg/ml - solution for injection - exenatide - byetta is indicated as an adjunct to diet and exercise to improve glycimic control in adults with type 2 diabetes mellitus.byetta is indicated as adjunctive therapy to improve glycemic control in patients with type 2 diabetes mellitus who are taking metformin or a sulfonylurea , alone or in combination, but have not achieved adequate glycemic control.
फ़िलिपींस -
अंग्रेज़ी -
FDA (Food And Drug Administration)
exenatide 250 mcg/ml (5mcg/dose) solution for injection (sc)
astrazeneca pharmaceuticals (phils.), inc. - byetta® - solution for injection (sc) - 250 mcg/ml (5mcg/dose)